Pfizer, BioNTech Seek Full FDA Approval For Covid Vaccine; Shares Pop

Pfizer, BioNTech Seek Full FDA Approval For Covid Vaccine; Shares Pop
·2 min read

Pfizer and BioNTech asked for full Food and Drug Administration approval of their Covid vaccine on Friday, leading BioNTech stock to pop. That followed patent questions that hurt shares.